scispace - formally typeset
H

Hiroaki Shimokawa

Researcher at Tohoku University

Publications -  976
Citations -  56856

Hiroaki Shimokawa is an academic researcher from Tohoku University. The author has contributed to research in topics: Heart failure & Endothelium. The author has an hindex of 111, co-authored 949 publications receiving 48822 citations. Previous affiliations of Hiroaki Shimokawa include University of Nebraska Medical Center & Nagoya University.

Papers
More filters
Journal ArticleDOI

Colchicine, a microtubule depolymerizing agent, inhibits myocardial apoptosis in rats.

TL;DR: Results indicate that a microtubule-depolymerizing agent could be a potential therapeutic strategy for treatment of heart failure.
Journal ArticleDOI

Prognostic Impact of New-Onset Atrial Fibrillation in Patients With Chronic Heart Failure – A Report From the CHART-2 Study –

TL;DR: Onset of new AF, but not a history of AF, is associated with increased mortality in CHF patients, especially in the first year, and on inverse probability of treatment weighting analysis using propensity score, RAS inhibitors and statins were associated with reduced incidence of newAF, and diuretics wereassociated with increase ofnew AF.
Journal ArticleDOI

Endothelium-dependent relaxation in response to aggregating platelets in porcine femoral veins and its modulation by diet.

TL;DR: The protective role of the venous endothelium against aggregating platelets and its modulation by diet is examined and platelet-induced contractions were significantly reduced in rings with endothelio from oil-fed pigs, whereas the contraction levels were comparable in rings without endothelia among the three groups.
Journal ArticleDOI

Circadian Variation of Rho-Kinase Activity in Circulating Leukocytes of Patients With Vasospastic Angina

TL;DR: Rho-kinase activity exhibits distinct circadian variation associated with alterations in coronary vasomotor responses and autonomic activity in VSA patients, whereas no such variation was noted in non-VSA patients.